Trial Profile
Phase 2a study of PrEP-001 for the prevention of influenza.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 06 Jun 2017
Price :
$35
*
At a glance
- Drugs Poly ICLC (Primary)
- Indications Influenza virus infections
- Focus Therapeutic Use
- 06 Jun 2017 New trial record